Current Concepts of Chronic Hepatitis

References

• Wright E. C., Sfeff L. B., Berk P. D., et al. Treatment of chronic active hepatitis: an analysis of three controlled clinical trials. Gastroenterology 1977; 73: 1422–1430
   PubMed Web of Science ®Google Scholar
• Leevy C. M., Tygstrup N. Standardisation of nomenclature, diagnostic criteria and diagnostic morphology. Diseases of the Liver and Biliary Tract. Karger, Basel 1976; 9–10
   Google Scholar
• Cooksley W. G. E., Cowen A. E., Powell L. W. The incidence of oxyphenisatin ingestion in active chronic hepatitis: a prospective controlled study of 29 patients. Aust. N.Z. J. Med. 1973; 3: 124–128
   PubMedGoogle Scholar
• Goldberg S. J., Mendenhall C. L., Connell A. M., Chedid A. ‘Non alcoholic’ chronic hepatitis in the alcoholic. Gastroenterology 1977; 72: 598–604
   PubMed Web of Science ®Google Scholar
• Triger D. R., Millward-Sadler G. H., Czaykowski A. A., et al. Alpha-1-antitrypsin deficiency and liver disease in adults. Q. J. Med. 1976; 45: 351–372
   Google Scholar
• Sternlieb I., Scheinberg I. H. Chronic hepatitis as a first manifestation of Wilson's disease. Ann. Int. Med. 1972; 76: 59–64
   PubMed Web of Science ®Google Scholar
• Summerskill W. H. J. Chronic active hepatitis re-examined: prognosis hopeful. Gastroenterology 1974; 66: 450–464
   PubMed Web of Science ®Google Scholar
• Schalm S. W., Summerskill W. H. J., Gitnick G. I., Elveback L. W. Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis Bs antigen. Gut 1976; 17: 781–786
   PubMed Web of Science ®Google Scholar
• Wright R., Millward-Sadler G. H. Chronic hepatitis. Liver and Biliary Disease, R. K. WrightG. M. M. Alberti, J. Karron, G. H. Millward-Sadler. Saunders, London 1979; 647–687
   Google Scholar
• Read A. E., Sherlock S., Harrison C. V. Active ‘juvenile’ cirrhosis considered as part of a systemic disease and the effect of corticosteroid therapy. Gut 1963; 4: 378–393
   PubMed Web of Science ®Google Scholar
• Popper H., Schaffner F. Chronic hepatitis: taxonomic, etiologic and therapeutic-problems. Progress in Liver Disease V, H. Popper, F. Schaffner. Grune and Stratton, New-York 1976; 531–558
   Google Scholar
• Boyer J. L., Klatskin G. Pattern of necrosis in acute viral hepatitis: prognostic value of bridging (sub-acute hepatic necrosis). N. Engl. J. Med. 1970; 283: 1063–1071
   PubMed Web of Science ®Google Scholar
• De Groote J., Desmet V. J., Gedigk P., et al. A classification of chronic hepatitis. Lancet 1968; ii: 626–628
   Google Scholar
• Dietrichson O. Chronic persistent hepatitis. A clinical, serological and prognostic study. Scand. J. Gastroenterol. 1975; 10: 249–255
   PubMed Web of Science ®Google Scholar
• Bagenstoss A. H., Soloway R. D., Summerskill W. H.J, et al. Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution. Hum. Pathol. 1972; 3: 183–198
   PubMed Web of Science ®Google Scholar
• Burns J. Immuno peroxidase localisation of hepatitis B antigen (HB) in formalin-paraffin processed liver tissue. Histochemistry 1975; 44: 133–135
   PubMedGoogle Scholar
• Hadziyannis S., Gerber M. A., Vissoulis C., Popper H. Cytoplasmic hepatitis B antigen in ‘ground glass’ hepatocytes of carriers. Arch. Pathol. 1973; 96: 327–330
   PubMedGoogle Scholar
• Shikata T., Uzama T., Yoshiwara N, et al. Australia antigen in paraffin section: detection of cytoplasmic inclusion bodies. Jpn. J. Exp. Med. 1974; 44: 25–36
   PubMedGoogle Scholar
• Chadwick R. G., Galizzi J., Jr, Heathcote J., et al. Chronic persistent hepatitis: hepatitis B virus markers and histological follow-up. Gut 1979; 20: 372–377
   PubMed Web of Science ®Google Scholar
• Paronetto F., Rubin E., Popper H. Local formation of γ globulin in the diseased liver and its relation to hepatic necrosis. Lab. Invest. 1962; 11: 150–158
   PubMed Web of Science ®Google Scholar
• Lipman T. O., Seeff L. B., Dobbins W. O. Chronic active hepatitis. Prolonged survival without treatment. Dig. Dis. 1977; 22: 43–48
   Google Scholar
• Boyer J. L. Chronic hepatitis -a perspective on classification and determinants of prognosis. Gastroenterology 1976; 70: 1161–1171
   PubMed Web of Science ®Google Scholar
• Schaefner F., Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology 1963; 44: 239–242
   Google Scholar
• Poulsen H., Christofeersen P. Abnormal bile duct epithelium in chronic aggressive hepatitis and cirrhosis. Hum. Pathol. 1972; 3: 217–225
   PubMed Web of Science ®Google Scholar
• Kloppel G., Siefert G., Linder H., et al. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Virchows Arch. (Pathol. Anat.) 1977; 373: 143–160
   Google Scholar
• DeGroote J., Fevery J., Lepoutre L. Long term follow up of chronic active hepatitis of moderate severity. Gut 1978; 19: 510–513
   PubMed Web of Science ®Google Scholar
• Scheuer P. J. Liver Biopsy Interpretation, 2nd ed. Bailliere Tindall, London 1973; 78–84
   Google Scholar
• Hadziyannis S. J. Hepatocellular carcinoma and type B hepatitis. Clinics in Gastroenterology, J. A. D. Bouchier, B. N. Brooke, W. Cleutzfeldt, N. C. Hightower, H. Worming. Saunders, London 1980; 117–134
   Google Scholar
• Sumithran E., McSween R. N. M. An appraisal of the relationship between primary hepatocellular carcinoma and hepatitis B virus. Histopathology 1979; 3: 447–458
   Google Scholar
• Triger D. R. The liver as an immunological organ. Gastroenterology 1976; 71: 162–164
   Google Scholar
• Joske R. A., Laurence B. H. Familial cirrhosis with autoimmune features and raised immunological levels. Gastroenterology 1970; 59: 546–552
   PubMed Web of Science ®Google Scholar
• Galbraith R. M., Smith M., MacKenzie R. M., et al. High prevalence of sero-immunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N. Engl. J. Med. 1974; 290: 63–69
   PubMed Web of Science ®Google Scholar
• Joske R. A., King W. E. The ‘L.E.-cell’ phenomenon in active chronic viral hepatitis. Lancet 1955; i: 477–480
   Google Scholar
• MacKay I. R., Morris P. J. Association of autoimmune active chronic hepatitis with HL-AI-8. Lancet 1972; ii: 793–795
   Google Scholar
• Opelz G., Vogten A. J. M., Summerskill W. H.J., et al. HLA determinants in chronic active liver disease: possible relation of HLA-Dw3 to prognosis. Tissue Antigens 1977; 9: 36–40
   PubMedGoogle Scholar
• Benacerraf B., Katz D. H. The nature and function of histocompatibility-linked immune response genes. Immunogenetics and Immunodeficiency, B. Benacerraf. MTP Press, Lancaster 1975; 117–143
   Google Scholar
• Triger D. R., MacCallum F. O., Kurtz J. B., et al. Raised antibody titres to measles and rubella viruses in chronic active hepatitis. Lancet 1972; i: 665–667
   Google Scholar
• Galbraith R. M., Eddleston A. L. W. F., Williams R., et al. Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet 1976; i: 930–934
   Google Scholar
• Eddleston A. L. W. F., Williams R. HLA system and liver disease. Progress in Liver Disease, H. Popper, F. Schaffner. Grune & Stratton, New York 1979; Vol. VI: 285–299
   Google Scholar
• Eddleston A. L. W. F. Genetically determined immune hyperreactivity in human liver disease. Proc. R. Soc. Med. 1979; 70: 525–529
   Google Scholar
• Freudenberg J., Baumann H., Arnold W., et al. HLA in different forms of chronic-active hepatitis: a comparison between adult patients and children. Digestion 1977; 15: 260–270
   Google Scholar
• Hulls W. D., Hillis A., Bias W. B., et al. Associations of hepatitis B Surface antigenacmia with HLA locus B specificities. N. Engl. J. Med. 1977; 296: 1310–1314
   Google Scholar
• Lee W. M., Reed W. D., Mitchell C. G., et al. Cellular and humoral immunity to hepalilis-B surface antigen in active chronic hepatitis. Br. Med. J. 1975; 1: 705–708
   PubMed Web of Science ®Google Scholar
• Primack A., Vogel C. L., Barker L. F. Immunological studies in Ugandan patients with hepatocellular carcinoma. Br. Med. J. 1973; 1: 16–19
   PubMedGoogle Scholar
• Meyer zum Buschenfelde K. H., Miescher P. A. Liver specific antigens: purification and characterization. Clin. Exp. Immunol. 1972; 10: 89–102
   PubMed Web of Science ®Google Scholar
• Miller J., Smith M. G. M., Mitchell C. G., et al. Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet 1972; ii: 296–297
   Google Scholar
• Jensen D. M., McFarlane I. G., Portmann B. S., et al. Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N. Engl J. Med. 1978; 299: 1–7
   PubMed Web of Science ®Google Scholar
• Meyer zum Buschenfelde K. H., Kossling F. K., Miescher P. A. Experimental chronic active hepatitis in rabbits following immunization with human liver proteins. Clin. Exp. Immunol. 1972; 10: 99–108
   Google Scholar
• Thomson A. D., Cochrane A. M. G., McFarlane I. G., et al. Lymphocyte cytotoxicity to isolated hepatocytes in chronic-active hepatitis. Nature 1974; 252: 721–722
   PubMed Web of Science ®Google Scholar
• Cochrane A. M. G., Moussouros A., Thomson A. D., et al. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet 1976; i: 441–444
   Google Scholar
• Kawanishi H., MacDermott R. P. K-cell mediated antibody-dependent cellular cytotoxicity in chronic active liver disease. Gastroenterology 1979; 76: 151–158
   PubMed Web of Science ®Google Scholar
• Mieli Vergani G., Vergani D., Jenkins P., et al. Lymphocyte cytotoxicity to autologous hepatocytes in chronic active hepatitis. Gut 1979; 20: A435
   Google Scholar
• Eddleston A. L. W. F., Williams R. Inadequate antibody response to HBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet 1974; ii: 1543–1545
   Google Scholar
• Zilko P. J., Dawkins R. L., Holmes K., et al. Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8 DRW3 and cold reactive lymphocytotoxic antibodies. Clin. Immunol. Immunopathol. 1979; 14: 222–230
   Google Scholar
• Hodgson H. J. F., Wands J. R., Isselbacher K. J. Suppressor lymphocytes: their role in modulating the immune response in acute and chronic active hepatitis. Gastroenterology 1977; 72: 1070
   Google Scholar
• Bartholomaeus W. N., Reed W. D., Joske R. A. Autoimmune responses to liver antigen in man regulated by suppressor T lymphocytes. Gastroenterology 1978; 75: 954
   Google Scholar
• Behrens U. J., Paronetto F. Studies on ‘liver-specific’ antigens, I. Evaluation of the liver specificity of ‘LSP’ and ‘LP-z’. Gastroenterology 1979; 77: 1045–1052
   PubMedGoogle Scholar
• Conn H. O. Chronic hepatitis: reducing an iatrogenic enigma to a workable puzzle. Gastroenterology 1976; 70: 1182–1184
   PubMed Web of Science ®Google Scholar
• Scullard G. H., Robinson W. S., Merigan T. C., Gregory P. B. The effect of immuno suppressive therapy on hepatitis B viral infection in patients with chronic hepatitis. Gastroenterology 1979; 77: A40
   Google Scholar
• Jones J. H., Lennard Jones J. E., Morson B. C., et al. Numerical taxonomy and discriminant analysis applied to non-specific colitis. Q. J. Med. 1973; 42: 715–732
   PubMedGoogle Scholar